3.11
5.18%
-0.17
Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
1.57%
13.21
|
13.00 | 13.24 | 11.13 | 10.68 |
Cost Of Revenue |
2.48%
4.679
|
4.798 | 6.617 | 4.737 | - |
Gross Profit |
3.94%
8.527
|
8.204 | 6.624 | 6.397 | - |
Operating Expenses
|
17.55%
12.44
|
10.58 | 10.83 | 11.00 | 35.48 |
Interest Income/Expense |
80.97%
2.273
|
1.256 | 1.373 | 1.435 | 1.65 |
Benefits Costs and Expenses |
39.79%
21.22
|
15.18 | 18.75 | 3.066 | 23.03 |
Costs And Expenses |
11.30%
17.12
|
15.38 | 17.45 | 15.74 | 33.74 |
Depreciation and Amortization |
76.89%
0.467
|
0.264 | 0.289 | 0.325 | 0.397 |
Operating Income/Loss |
64.54%
-3.911
|
-2.377 | -4.209 | -4.605 | -10.71 |
Income/Loss From Continuing Operations Before Tax |
268.28%
-8.01
|
-2.175 | -5.508 | 8.068 | -12.35 |
Income Tax Expense/Benefit |
172.14%
0.101
|
-0.14 | 0.284 | - | - |
Income/Loss From Continuing Operations After Tax |
298.57%
-8.111
|
-2.035 | -5.792 | 8.068 | -12.35 |
Net Income/Loss
|
298.57%
-8.111
|
-2.035 | -5.792 | 8.068 | -12.35 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
96.90%
2.0031
|
64.68 | 57.35 | 55.63 | 1.9062 |
Diluted Average Shares |
100.40%
-0.2579
|
64.68 | 57.35 | 73.79 | 1.9062 |
Basic Earnings Per Share |
333.33%
-0.13
|
-0.03 | -0.10 | 0.15 | -0.22 |
Diluted Earnings Per Share |
333.33%
-0.13
|
-0.03 | -0.10 | 0.11 | -0.22 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):